BLADDR2017

The Global Congress on Bladder Cancer brings together top experts and delegates from several disciplines, for an in-depth discussion of the different aspects of bladder cancer, with a focus on difficulties and dilemmas of clinical decision making, settled in an inspiring location.

Thromboprophylaxis in muscle invasive, locally advanced or metastatic urothelial cancer with or without chemotherapy

Abdullah

Omar

Warwick Medical School/University of Warwick

Coventry

United Kingdom

View abstract

The Y shaped ileal neobladder as a simple and practical solution for Egyptian bladder cancer patients

Ahmed Abdelkarim

Sharif

The national cancer Institute Cairo University

Cairo

Egypt

View abstract

Factors Affecting Survival in Urinary Bladder Cancer Egyptian Patients: A Multicentre Retrospective Study

Aly Nagy

Ahmed

Faculty of Medicine, Ain Shams University

Cairo

Egypt

View abstract

The role of conductive hyperthermia with mitomycin in High Risk Non Muscle Invasive Bladder Cancer that has failed BCG therapy

Ashton

Annelisse

Royal Surrey County Hospital

Guildford

View abstract

Flexible cystoscopy with narrow band imaging instead of rigid cystoscopy and biopsy in initial surveillance of high risk non muscle invasive bladder cancer

Ayres

Benjamin

St George's Hospital

London

View abstract

Outpatient transurethral laser ablation (TULA) for urothelial tumours using the 1470 nm diode laser: Our experience so far

Bedi

Nishant

Northwick Park Hospital

London

View abstract

Are the classic factors predicting overall and disease-free survival after surgery for invasive bladder cancer?

Bernardino

Rui

Centro Hospitalar de Lisboa Central

Lisboa

Portugal

View abstract

Hyperthermic intravesical chemotherapy for BCG-unresponsive or BCG ineligible non-muscle invasive bladder cancer patients

Boormans

Joost

Erasmus MC Cancer Institute

Rotterdam

The Netherlands

View abstract

Second-Line Treatment Patterns of Metastatic Urothelial Carcinoma in Europe

Clark

Otávio

Evidencias

São Paulo

Brazil

View abstract

Prediction of progression to MIBC for pT1 bladder cancer: development of a clinical decision-making tool

D'Andrea

David

Medical University of Vienna

Vienna

Austria

View abstract

Does Rectal Volume Affect Bladder Emptying in Patient’s Undergoing Radical Radiotherapy for Bladder Cancer?

Derby

Sarah

Aberdeen Royal Infirmary

Aberdeen

Scotland

View abstract

A Rare Case of Chin Cutaneous Metastasis from Transitional Cell Carcinoma of Bladder in a Patient who Underwent Radical Cystectomy

Di Franco

Carmelo Agostino

University Hospital Policlinico S.Matteo

Pavia

Italy

View abstract

Open versus Laparoscopic Radical Cystectomy: a single centre 6-year review

Dosis

Alexios

Royal Preston

Preston

View abstract

Radical Treatment of Muscle Invasive Bladder Cancer- are options equal??

Fackrell

David

University Hospital Birmingham, Heart of England Foundation Trust

Birmingham

United Kingdom

View abstract

Micturition syncope: a case report

Falcão

Gil

Centro Hospitalar Lisboa Central (CHLC)

Lisbon

Portugal

View abstract

Nephrogenic adenoma of the urinary bladder after external pelvic radiotherapy – a rare diagnostic

Fernandes

Francisco

Centro Hospitalar Lisboa Central

Lisboa

Portugal

View abstract

Do Patient’s With High Risk Non-Muscle Invasive Bladder Tumours Require CT Thorax? A Change in South West Regional Practice

Gilliland

Niall

Southmead

Bristol

England

View abstract

How to Solve A Problem Like Cancer Targets

Gilliland

Niall

Southmead Hospital

Bristol

England

View abstract

A Multi-Center, Single-Arm, Open-Label Phase 1b Study of a Novel FGFR3 Inhibitor (B-701) Combined with Pembrolizumab in Subjects with Locally Advanced or Metastatic Urothelial Carcinoma who have Progressed Following Platinum-based Chemotherapy

Gladdines

Werner

BioClin Therapeutics

Leiden

Netherlands

View abstract

Chemohyperthermia with Mitomycin C and COMBAT system in High Risk Non-Muscle Invasive Bladder Cancer patients: Initial experience in a single center

González-Padilla

Daniel A.

Hospital Universitario 12 de Octubre

Madrid

Spain

View abstract

Evaluation of gene and protein expression changes in mice bladder tissue and human urothelium after treated with N-butyl-N- (4-hydroxybutyl) nitrosamine (BBN), dimethylarsonic acid (DMA) and sodium arsenite (NaAsO2)

Haque

Mohammad Mezbahul

National Chiayi University

Chiayi

Taiwan

View abstract

Managing Bladder Cancer Pain With Morphine May Have Detrimental Consequences on Patient Outcomes? In Vitro Studies

Harper

Phil

University Hospital Southampton

Southampton

England

View abstract

Cxcr2 as a novel regulator of inflammation-dependent tumour pathogenesis in invasive bladder cancer

Ismail

Nur Faezah Binti

Queen Elizabeth University Hospital, University of Glasgow

Glasgow

United Kingdom

View abstract

Increased tumourigenesis and suppression of acute inflammation by FGFR3 mutation in invasive bladder cancer

Iwata

Tomoko

Queen Elizabeth University Hospital, University of Glasgow

Glasgow

United Kingdom

View abstract

Presentation of bladder tumor in female at rural area of Nepal

Karki

kushal

KIST Medical college teaching hospital

Lalitpur

Nepal

View abstract

New prognostic factors in non muscle invasive bladder carcinoma

Lakmichi

Mohamed Amine

University hospital Mohamed the VIth, faculty of medecine, University Cadi Ayyad

Marrakech

Morocco

View abstract

KEYNOTE-361: Phase 3 Study of Pembrolizumab ± Chemotherapy Versus Chemotherapy Alone in Advanced Urothelial Cancer

Loriot

Yohann

Gustave Roussy, Université Paris-Saclay

Villejuif

France

View abstract

BLADDER TUMOUR VARIANTS : AN INDIAN CENTRE EXPERIENCE

MAHADIK

RAJAT

AMRITA INSTITUTE OF MEDICAL SCIENCES AND RESEARCH CENTRE

KOCHI

INDIA

View abstract

PLATIN-BASED NEOADJUVANT CHEMOTHERAPY FOR MUSCULE INVASIVE BLADDER CANCER: THE FIRST 5 YEARS OF EXPERIENCE OF A SINGLE INSTITUTION.

Moreira Pinto

João

Hospital Beatriz Ângelo

Loures

Portugal

View abstract

Primary Proximal Adenocarcinoma of the Urethra – A Case Report

Mendiola

Dinno Francis

National Kidney and Transplant Institute

Manila

Philippines

View abstract

IS 4 DAYS HOSPITAL STAY POST ROBOTIC RADICAL CYSTECTOMY FEASIBLE; A CHALLENGE BEYOND MULTIDISCIPLINARY ENHANCED RECOVERY PROGRAM AFTER MINIMAL INVASIVE SURGERY

Moschonas

Dimitrios

Royal Surrey County Hospital NHS Foundation Trust

Guildford

United Kingdom

View abstract

High grade T1 bladder urothelial carcinoma: Optimal management

Nassir

Anmar

King Abdullah Medical City ,Umm-Al Qura University

Makkah

Saudi Arabia

View abstract

Benefits of implementing an enhanced recovery pathway in laparoscopic radical cystectomy

Parejo

Victor

Corporació Sanitària Parc Taulí

Sabadell

Spain

View abstract

Xpert Bladder Cancer Monitor for Bladder Cancer Surveillance: First Experiences from a novel mRNA-based Urine Test

Pichler

Renate

Medical University Innsbruck

Innsbruck

Austria

View abstract

First-Line Pembrolizumab (pembro) in Cisplatin-Ineligible Advanced Urothelial Cancer (UC): Biomarker Findings and Mature Clinical Results From KEYNOTE-052

Powles

Thomas

Barts Cancer Institute, Queen Mary University of London

London

United Kingdom

View abstract

Complications following continuous and interrupted suturing for ureteroileal anastomosis in patients undergoing radical cystectomy for bladder cancer

prakash

gagan

Tata Memorial Hospital

Mumbai

India

View abstract

Whole exome sequencing-based mutation identification for patient-specific ddPCR assays for tracking of urothelial bladder cancer

Pritchard

John

Queen Elizabeth University Hospital, University of Glasgow

Glasgow

United Kingdom

View abstract

Minimal invasive treatment of Nonfunctional Paraganglioma of the urinary Bladder : A case report

Saada

Hesham

King Abdullah Medical City ,Umm-Al Qura University

Makkah

Saudi Arabia

View abstract

Trimodally treatment of invasive bladder cancer. Institutional experience of over 20 years

Sade

juan Pablo

INSTITUTO ALEXANDER FLEMING

buenos aires

Argentina

View abstract

Prospective study of outcomes following neo-adjuvant chemotherapy (gemcitabine + cisplatin) in patients of muscle invasive urinary bladder cancer

Sinha

Rahul Janak

King George Medical University

Lucknow

India

View abstract

Diagnostic accuracy of white light, SPIES and PDD cystoscopy in positive cytology and no tumor at imaging: how much the surgeon matter?

Soria

Francesco

Molinette Hospital

Turin

Italy

View abstract

A novel therapeutic approach to bladder cancer

Svanborg

Catharina

Lund university hospital

Lund

Sweden

View abstract

Clinical Outcomes from the Intensity-Modulated Pelvic Node and Bladder Radiotherapy (IMPART) Trial- A Phase 2 Single-Centre Study

Tan

Melissa

Institute of Cancer Research / Royal Marsden Hospital

Sutton

View abstract

Quality of life (QoL), Non Muscle Invasive Bladder Cancer (NMIBC) and Endovesical Treatments: Instillation matters.

Villacampa

Felipe

Hospital Universitario 12 de Octubre

Madrid

Spain

View abstract

Keeping the red patch out of theatre: Is it safe?

Yousuff

Mehreen

Guy's and St Thomas' NHS Foundation Trust

London

United Kingdom

View abstract